C55 Malignant neoplasm of uterus, part unspecified

Name of the Condition

• Malignant neoplasm of uterus, part unspecified
• Uterine cancer (unspecified part)

Summary

Malignant neoplasm of the uterus, part unspecified, refers to a cancerous growth originating in the uterus where the specific anatomical part is not documented. This condition is a type of gynecological cancer that can affect uterine function if untreated. It may spread to nearby tissues or other parts of the body.

Causes

The exact cause involves genetic mutations in uterine tissue leading to uncontrolled cell growth. Contributing factors may include hormonal imbalances, environmental exposures, and genetic predispositions.

Risk Factors

• Age, particularly over 50
• Obesity
• Hormone replacement therapy (especially estrogen-only)
• History of infertility or nulliparity
• Family history of uterine or colorectal cancer
• Diabetes
• Hypertension

Symptoms

• Abnormal vaginal bleeding (postmenopausal or between periods)
• Pelvic pain or pressure
• Unusual vaginal discharge
• Pain during intercourse
• Unintended weight loss
• Changes in bowel or bladder habits

Diagnosis

Diagnosis involves a physical examination by a healthcare provider, followed by imaging tests (e.g., ultrasound, MRI) to assess the uterus. A biopsy of uterine tissue may be performed to confirm malignancy. Additional tests, such as CT scans or PET scans, may be used to evaluate spread.

Treatment Options

Treatment depends on the cancer stage, grade, and patient health. Options may include surgery (e.g., hysterectomy), radiation therapy, chemotherapy, hormone therapy, or targeted therapy. Multimodal approaches are common.

Prognosis and Follow-Up

Prognosis varies based on cancer stage, grade, and response to treatment. Regular follow-up care, including physical exams and imaging, is typically recommended to monitor for recurrence. Early detection improves outcomes.

Complications

• Metastasis to other organs (e.g., lungs, bones)
• Bowel or bladder obstruction
• Infection
• Treatment-related side effects (e.g., fatigue, nausea)
• Lymphedema

Lifestyle & Prevention

• Maintain a healthy weight
• Engage in regular physical activity
• Limit alcohol consumption
• Manage chronic conditions (e.g., diabetes, hypertension)
• Discuss hormone therapy risks with a healthcare provider

When to Seek Professional Help

Seek care if experiencing abnormal vaginal bleeding, persistent pelvic pain, or unexplained weight loss. Prompt evaluation is important for early diagnosis and treatment.

Tips for Medical Coders

Use code C55 for malignant neoplasms of the uterus when the specific part (e.g., corpus, cervix) is not documented. Ensure documentation supports the diagnosis and aligns with clinical findings. Verify that the code is not used for benign conditions or specified uterine parts.